Lederspan (Triamcinolone Hexacetonide)

Triamcinolone hexacetonide is a potent glucocorticoid that binds to intracellular glucocorticoid receptors. The drug‑receptor complex alters gene transcription, suppressing the production of pro‑inflammatory cytokines and reducing immune‑cell activation, which together diminish inflammation and pain at the injection site.

The specific dose and injection volume of Lederspan are determined by the prescribing clinician based on the joint involved, severity of inflammation, and patient factors. Dosage decisions are individualized and should follow the prescriber’s instructions and local regulatory guidelines.

Safety data for triamcinolone hexacetonide in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Lederspan. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lederspan (triamcinolone hexacetonide) is a long‑acting glucocorticoid that provides prolonged anti‑inflammatory effects compared with shorter‑acting agents such as methylprednisolone acetate. Its high potency and extended duration can reduce the frequency of repeat injections, but clinicians must balance this against the potential for longer systemic exposure.

Lederspan should be stored at ambient temperature, preferably below 25 °C, in its original packaging. The product must be protected from light and moisture. Do not freeze or expose the vial to extreme temperatures, and keep it out of reach of children.

Lederspan is supplied as a sterile injectable solution for peri‑articular use. A qualified healthcare professional injects the medication directly into the affected joint using aseptic technique. The injection site is typically prepared with antiseptic, and the volume administered is based on the prescriber’s recommendation.

Serious risks include joint infection (septic arthritis), systemic adrenal suppression, tendon rupture, and rare cases of osteonecrosis. Patients should be monitored for signs of infection, unexpected pain, or systemic corticosteroid effects, and any concerning symptoms should prompt immediate medical evaluation.

Lederspan is contraindicated in patients with known hypersensitivity to triamcinolone hexacetonide or any component of the formulation, and it should be avoided in joints with active infection. Caution is also advised for individuals with uncontrolled diabetes, severe osteoporosis, or those receiving systemic corticosteroids where additional exposure may be harmful.